The AIDS Clinical Trials Unit (ACTU) is a federally funded center created to study persons with HIV and AIDS. Grant-funding comes from the AIDS Clinical Trials Group (ACTG), a clinical trials network funded by the National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institute of Health (NIH).
The ACTG was initially established in 1987 to broaden the scope of the AIDS research effort of the NIAID. The ACTG established and supports the largest network of expert clinical and translational investigators and therapeutic clinical trials units in the world, including sites in resource-limited countries. These investigators and units serve as the major resource for HIV/AIDS research, treatment, care, and training/education in their communities.
ACTU is one of 47 federally funded centers in the United States, Africa, Thailand, South America, and India. An ACTU is usually based at a University. Each local ACTU has a consumer group called the Community Advisory Board (CAB) that works to promote partnerships between study volunteers and researchers. Our ACTU is a unit specializing in clinical research, training, education and the care of persons with HIV/AIDS. The University of Cincinnati ACTU has been funded since 1987.